Danaher Corp. (DHR)

Precedente Chiudi:

$245.80

Aprire:

$243.68

Volume 24 ore:

2.65M

Capitalizzazione di mercato:

$182.64B

Reddito:

$22.52B

Utile/perdita netta:

$4.40B

Rapporto P/E:

31.09

EPS:

7.93

Flusso di cassa netto:

$5.55B

1 W Prestazione:

+4.70%

1M Prestazione:

-0.76%

6M Prestazione:

+27.31%

1 anno Prestazione:

+6.07%

Intervallo 1D:

$243.68

$248.10

Portata 52W:

$182.09

$269.61

Danaher Corp. Stock (DHR) Company Profile

Nome

Danaher Corp.

Settore

Healthcare (1191)

Industria

Diagnostics & Research (66)

Telefono

202-828-0850

Indirizzo

2200 Pennsylvania Avenue NW, Suite 800W, Washington, DC

Dipendente

67,000

Cinguettio

@Danaher_U

Prossima data di guadagno

2024-05-07

Ultimi documenti SEC

DHR's Discussions on Twitter

Danaher Corp. Stock (DHR) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2024-01-24	Downgrade	Barclays	Overweight → Equal Weight
2023-12-18	Iniziato	HSBC Securities	Hold
2023-12-13	Ripresa	Wolfe Research	Peer Perform
2023-12-07	Downgrade	Goldman	Buy → Neutral
2023-07-19	Iniziato	Raymond James	Outperform
2023-05-01	Iniziato	SVB Securities	Outperform
2023-04-26	Downgrade	BofA Securities	Buy → Neutral
2023-04-18	Aggiornamento	Wells Fargo	Equal Weight → Overweight
2023-01-05	Downgrade	Credit Suisse	Outperform → Neutral
2022-12-14	Iniziato	Deutsche Bank	Buy
2022-10-24	Downgrade	The Benchmark Company	Buy → Hold
2022-08-25	Iniziato	Credit Suisse	Outperform
2022-08-17	Ripresa	Bernstein	Outperform
2022-07-20	Iniziato	UBS	Buy
2022-06-01	Aggiornamento	RBC Capital Mkts	Sector Perform → Outperform
2022-04-25	Downgrade	Wells Fargo	Overweight → Equal Weight
2022-01-11	Iniziato	Bernstein	Outperform
2021-10-15	Ripresa	Cowen	Outperform
2021-09-10	Reiterato	BofA Securities	Buy
2021-08-05	Ripresa	Credit Suisse	Outperform
2021-07-23	Reiterato	Goldman	Buy
2021-07-16	Iniziato	The Benchmark Company	Buy
2021-04-07	Ripresa	Robert W. Baird	Outperform
2021-03-03	Ripresa	Barclays	Overweight
2020-12-02	Iniziato	Goldman	Buy
2020-11-25	Downgrade	RBC Capital Mkts	Outperform → Sector Perform
2020-11-10	Iniziato	KeyBanc Capital Markets	Overweight
2020-06-16	Aggiornamento	Wolfe Research	Peer Perform → Outperform
2020-04-02	Downgrade	Wolfe Research	Outperform → Peer Perform
2020-03-26	Aggiornamento	RBC Capital Mkts	Sector Perform → Outperform
2020-02-03	Reiterato	Needham	Buy
2020-01-08	Iniziato	Wells Fargo	Overweight
2020-01-07	Iniziato	Citigroup	Buy
2019-11-15	Ripresa	Stifel	Hold
2019-10-28	Reiterato	Needham	Buy
2019-10-14	Ripresa	Credit Suisse	Outperform
2019-07-19	Reiterato	Needham	Buy
2019-06-11	Iniziato	Piper Jaffray	Neutral
2019-05-30	Iniziato	Wolfe Research	Outperform
2019-04-17	Reiterato	Needham	Buy
2019-02-28	Reiterato	Needham	Buy
2019-02-25	Aggiornamento	Janney	Neutral → Buy
2019-01-03	Iniziato	Needham	Buy
2018-04-20	Reiterato	Stifel	Buy

Mostra tutto

Danaher Corp. Borsa (DHR) Ultime notizie

Honeywell (HON) Q1 Earnings Beat, Aerospace Sales Rise Y/Y

Zacks Investment Research

The Zacks Analyst Blog Highlights Danaher, Regeneron Pharmaceuticals, Palo Alto Networks, Workday and American Electric Power

Zacks Investment Research

Value Vs. Growth? Danaher Says Why Not Both?

Seeking Alpha

Top Stock Reports for Danaher, Regeneron Pharmaceuticals & Palo Alto Networks

Zacks Investment Research

Tesla To $180? Here Are 10 Top Analyst Forecasts For Wednesday

Benzinga

Stocks Rally On Weaker PMI Data, Tech Earnings Optimism, Dollar Falls: What's Driving Markets Tuesday?

Benzinga

Danaher Corp. Azioni (DHR) Dati Finanziari

Danaher Corp. (DHR) Reddito 2024

Danaher Corp. (DHR) Reddito netto 2024

Danaher Corp. (DHR) Flusso di cassa 2024

Danaher Corp. (DHR) Utile per azione 2024

Danaher Corp. Azioni (DHR) insider trading